EcoDrugPlus

Ribosomal Protein S26

Ensembl ID : ENSACLG00000025004
Gene Symbol: RPS26
3 Cross references
416 Possible Orthologues:

Ribosomal Protein S27a

Ensembl ID : ENSACLG00000002705
Gene Symbol: RPS27A
4 Cross references
254 Possible Orthologues:

Ribosomal Protein S28

Ensembl ID : ENSACLG00000008061
Gene Symbol: RPS28
3 Cross references
276 Possible Orthologues:

Ribosomal Protein S29

Ensembl ID : ENSACLG00000000915
Gene Symbol: RPS29
1 Cross references
246 Possible Orthologues:

Ribosomal Protein S3a

Ensembl ID : ENSACLG00000026015
Gene Symbol: RPS3A
4 Cross references
372 Possible Orthologues:

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSACLG00000019047
Gene Symbol: RPS4X
3 Cross references
497 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSACLG00000007312
Gene Symbol: RPS5
3 Cross references
257 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSACLG00000021384
Gene Symbol: RPS9
3 Cross references
237 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSACLG00000010838
Gene Symbol: RPLP0
3 Cross references
403 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSACLG00000012690
Gene Symbol: RPLP1
3 Cross references
386 Possible Orthologues:

Selectin E

Ensembl ID : ENSACLG00000025118
Gene Symbol: SELE
1 Cross references
165 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSACLG00000006678
Gene Symbol: LOC113033717
3 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).